Catalyst Event
Merck and Co Inc (MRK) · Earnings Release
From KEDI Global Obesity Care Industry Top 2+ Index (OBCI)
4/30/2026, 12:00:00 AM
Merck & Co. is scheduled to release its Q1 2026 earnings on April 30, 2026; impact is estimated as neutral pending the actual report, scheduled.
Korean Translation
머크, 2026년 4월 30일에 2026년 1분기 실적 발표 예정이며, 실적 발표 전까지 시장 반응은 중립적일 것으로 예상됨.
Related Recent Events
Novo Nordisk A/S (NVO) · Earnings Release
Novo Nordisk is scheduled to release its Q1 2026 earnings report before the market opens on May 6, 2026, with high importance estimated due to potential 10% price impact, expected.
5/6/2026, 12:00:00 AM
Life Time Group Holdings Inc (LTH) · Earnings Release
Life Time Group Holdings is scheduled to report its Q1 2026 financial results. A moderate market reaction is estimated for this standard earnings release scheduled.
5/5/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Earnings Release
Eli Lilly is scheduled to announce its first-quarter 2026 financial results on April 30, 2026, followed by a conference call. High impact is estimated due to significant market focus on GLP-1 sales growth scheduled.
4/30/2026, 12:00:00 AM
Amgen Inc (AMGN) · Earnings Release
Amgen is expected to report its Q1 2026 financial results after the market closes on April 30, 2026, scheduled. Analysts estimate a Low impact (~1-2%) as a standard scheduled reporting event, scheduled.
4/30/2026, 12:00:00 AM
Astrazeneca PLC (AZN) · Earnings Release
AstraZeneca's Q1 2026 results announcement is scheduled for April 29, 2026 scheduled
4/29/2026, 12:00:00 AM
Novartis AG (NVS) · Earnings Release
Novartis is scheduled to report Q1 2026 results on 2026-04-28; analysts forecast EPS of about USD 2.10, making this a near-term earnings catalyst with estimated low neutral impact until results are released. scheduled
4/28/2026, 12:00:00 AM